The $32 million privacy settlement between GoodRx Holdings, Inc., the advertising-technology firm
Criteo Corp. and GoodRx users has moved from proposal to an open claim process. On September 8, 2026,
U.S. District Judge Araceli Martínez-Olguín of the Northern District of California granted
preliminary approval (ECF No. 379), provisionally certified a nationwide settlement class and
appointed A.B. Data as the settlement administrator. Claims, requests to be excluded and objections
are all due December 29, 2026, and the final approval hearing is set for February 11, 2027.
Eligibility, the claim form, payment options and every deadline are laid out on OCA’s settlement
page,
GoodRx $32M privacy settlement: who qualifies and how to file.
GoodRx is a telehealth and prescription-coupon company used by millions of people each month for
discount coupons, telehealth visits and other health services. The plaintiffs allege that, when
people used GoodRx, the company collected personal and health information, including details about
their prescriptions and health conditions, email addresses and phone numbers, and then disclosed
that data to advertising and analytics companies through tracking technologies embedded on the
GoodRx platform. According to the plaintiffs, those technologies included JavaScript pixels,
software development kits (SDKs), cookies and application programming interfaces (APIs) from
Criteo, Meta Platforms and Google, and the third parties used the information for their own
purposes.
GoodRx and Criteo deny the allegations and deny that they violated any law. They agreed to settle to
avoid the expense and uncertainty of continued litigation. A settlement is a compromise; it is not a
finding or admission of wrongdoing by either company.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Claims Open · Preliminary Approval Granted
Approved September 8, 2026 · final approval hearing February 11, 2027
Claim Deadline
December 29, 2026
11:59 p.m. ET online · postmarked by this date if mailed · opt-outs and objections due the same day
Settlement Fund
$32,000,000
Non-reversionary · paid by GoodRx and Criteo · net fund divided equally among valid claims
Who's Covered
U.S. GoodRx users before April 20, 2024
Users of any GoodRx website, app or service, including GoodRx Gold, GoodRx Care and HeyDoctor
The consolidated complaint asserts a range of privacy and consumer-protection claims, including
intrusion upon seclusion, unjust enrichment, negligence, negligence per se, and violations of the
California Confidentiality of Medical Information Act (CMIA), the California Invasion of Privacy Act
(CIPA), the California Consumers Legal Remedies Act (CLRA), California’s Unfair Competition Law (UCL),
New York’s General Business Law and the Illinois Consumer Fraud and Deceptive Business Practices Act.
According to the plaintiffs, the alleged data sharing took place from at least 2017 to 2020.
The lawsuit followed a February 1, 2023 action by the Federal Trade Commission, which alleged that
GoodRx violated the FTC Act and the agency’s Health Breach Notification Rule by disclosing users’
personal information and details about their medications and health conditions to third parties.
That FTC matter is separate from this private class action and this settlement.
GoodRx and Criteo will pay a combined, non-reversionary $32,000,000 into a settlement fund.
“Non-reversionary” means no unclaimed money goes back to the companies once the settlement takes
effect. The fund pays for settlement notice and administration, taxes, fund account costs,
court-approved attorneys’ fees and expenses, and service awards for the class representatives;
whatever remains, the net settlement fund, is split equally among everyone who files a valid, timely
claim. The exact per-person amount depends on how many people file, and no estimate has been
published.
The claim form lets class members choose how to be paid: PayPal, Venmo, Zelle, a virtual prepaid
card or a mailed paper check. The online form does not ask for receipts, documents or the codes
printed on the emailed notice; claimants attest that they lived in the United States and used a
GoodRx website, app or service before April 20, 2024, and sign electronically.
Class Counsel, Lowey Dannenberg, P.C. and Bursor & Fisher, P.A., have said they will ask the court to
approve attorneys’ fees of up to one-third of the fund (about $10.67 million) plus up to $125,000 in
litigation expenses, and service awards of up to $2,000 for each named plaintiff. Those motions are
due November 24, 2026, and the court decides the amounts separately from whether it approves the
settlement itself.
The settlement class the court provisionally certified is all natural persons in the United States
who used any website, app, or service made available by or through GoodRx at any time prior to April
20, 2024. That includes the main GoodRx website and app as well as GoodRx Gold, GoodRx Care and
HeyDoctor. Excluded from the class are GoodRx and Criteo and their affiliates, parents, subsidiaries,
officers and directors; Meta and Google; the people who opt out; and the judges presiding over the
case and their clerks.
This settlement resolves the case only as to GoodRx and Criteo. The plaintiffs’ claims against Meta
Platforms and Google, which the settlement papers call the “Remaining Defendants,” are not part of
this $32 million agreement and continue in the same litigation. A separate resolution or trial
involving Meta and Google could still follow.
The preliminary approval order set the following schedule. The court can move any of these dates,
and changes are posted on the official
GoodRx Privacy Settlement website.
- September 8, 2026: preliminary approval granted.
- By October 30, 2026: notice to the class begins, largely by email.
- November 24, 2026: deadline for Class Counsel’s motions for final approval, attorneys’ fees and expenses, and service awards.
- December 29, 2026: deadline to file a claim (online by 11:59 p.m. Eastern Time, or postmarked by mail), to mail a request for exclusion, and to file an objection with the court.
- February 11, 2027, at 11:00 a.m.: final approval hearing in Oakland. The notice says the date or time may change and the hearing could be held remotely.
The court will decide at or after the February 11, 2027 hearing whether to grant final approval and
how much to award in fees, expenses and service awards. If it approves the settlement, payments go
out within 45 days after the Effective Date, which arrives only after final approval and the end of
any appeals. The notice cautions that appeals can take a year or more. No payment date had been
announced as of October 14, 2026.
The case now carries the Oakland division number 4:23-cv-00501-AMO. The settlement agreement and
other earlier filings, and the original version of this article, used the San Francisco designation
3:23-cv-00501-AMO for the same case.
Who is covered by the GoodRx privacy settlement?
The settlement class the court provisionally certified is all natural persons in the United States who used any website, app or service made available by or through GoodRx at any time before April 20, 2024, including GoodRx Gold, HeyDoctor and GoodRx Care. GoodRx, Criteo and their affiliates, parents, subsidiaries, officers and directors, Meta and Google, anyone who opts out, and the presiding judges and their clerks are excluded.
How much is each GoodRx settlement payment?
No per-person figure has been published. GoodRx and Criteo are paying a non-reversionary $32,000,000, and after notice and administration costs, taxes, fund costs, court-approved attorneys’ fees and expenses, and service awards are paid, the net fund is divided equally among everyone who files a valid, timely claim. The amount each person receives depends on how many valid claims are filed.
What does the GoodRx claim form ask for?
The online claim form on the official settlement website asks for name, street address, email, phone number, a payment method (PayPal, Venmo, Zelle, a virtual prepaid card or a mailed check), a checkbox attesting to U.S. residence and GoodRx use before April 20, 2024, and an electronic signature. It does not ask for receipts, documents, or the Claimant ID code and Confirmation code printed on the emailed notice. The administrator can review and audit claims.
What is the GoodRx settlement claim deadline?
Claims are due December 29, 2026: online by 11:59 p.m. Eastern Time, or by mail postmarked no later than that date. Requests to be excluded must be mailed and postmarked by December 29, 2026, and written objections must be filed with the court by the same date.
What about Meta and Google?
The settlement resolves the case only against GoodRx and Criteo. The plaintiffs’ claims against Meta Platforms and Google continue in the same litigation, and those two companies are not part of the $32 million deal or its release.
Is the GoodRx settlement legitimate?
It is a real class action settlement in Doe, et al. v. GoodRx Holdings, Inc., et al., No. 4:23-cv-00501-AMO, in the U.S. District Court for the Northern District of California, which granted preliminary approval on September 8, 2026. The court’s order directs the administrator, A.B. Data, to run the official settlement website at goodrxprivacysettlement.com, where claims are filed. Final approval is still pending, and no money is paid before the court grants it.
When will GoodRx settlement payments be sent?
No payment date has been announced. The final approval hearing is set for February 11, 2027, and under the settlement agreement payments go out within 45 days after the Effective Date, which comes only after final approval and the end of any appeals.
- Order Preliminarily Approving the Proposed Class Action Settlement, Doe, et al. v. GoodRx Holdings, Inc., et al., No. 4:23-cv-00501-AMO (N.D. Cal.), entered September 8, 2026 (ECF No. 379).
- Notice of Proposed Class Action Settlement, summary notice and claim form, posted on the settlement website’s court documents page.
- Amended Class Action Settlement Agreement and Release dated November 19, 2025, and the March 24, 2026 addendum, filed June 1, 2026 (ECF Nos. 357-2 and 357-6).
- The official settlement website’s online claim form and FAQ, reviewed October 14, 2026.
OpenClassActions.com is a consumer news and information site, not a law firm. This article is general
information about the GoodRx privacy settlement. It is not legal advice, and reading it does not create
an attorney-client relationship.
For more class actions keep scrolling below.
Settlement Amount
$32,000,000 (GoodRx & Criteo)
Case Title
Doe, et al. v. GoodRx Holdings, Inc., et al.
Case Number
4:23-cv-00501-AMO
Court
U.S. District Court, Northern District of California (Oakland)
Final Approval Hearing
February 11, 2027 at 11:00 AM
Date may change; may be held remotely
Administrator
A.B. Data, Ltd.